{"id":"methotrexate-tablets","safety":{"commonSideEffects":[{"rate":"10-30","effect":"Myelosuppression (anemia, leukopenia, thrombocytopenia)"},{"rate":"10-25","effect":"Mucositis / stomatitis"},{"rate":"10-20","effect":"Nausea and vomiting"},{"rate":"5-15","effect":"Hepatotoxicity"},{"rate":"5-10","effect":"Nephrotoxicity"},{"rate":"5-10","effect":"Neurotoxicity (at high doses)"},{"rate":"5-10","effect":"Alopecia"},{"rate":"5-15","effect":"Infection"}]},"_chembl":{"chemblId":"CHEMBL2074969","moleculeType":"Small molecule","molecularWeight":"841.79"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"By inhibiting dihydrofolate reductase, methotrexate prevents the conversion of dihydrofolate to tetrahydrofolate, disrupting one-carbon transfer reactions essential for nucleotide synthesis. This leads to suppression of rapidly dividing cells, including cancer cells and activated immune cells. At lower doses, it also has immunosuppressive and anti-inflammatory effects through adenosine release and other mechanisms.","oneSentence":"Methotrexate inhibits dihydrofolate reductase, blocking the synthesis of purines and pyrimidines required for DNA replication and cell division.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:54:41.487Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute lymphoblastic leukemia (ALL)"},{"name":"Osteosarcoma"},{"name":"Breast cancer"},{"name":"Lung cancer"},{"name":"Rheumatoid arthritis"},{"name":"Psoriasis"},{"name":"Crohn's disease"}]},"trialDetails":[{"nctId":"NCT06816134","phase":"PHASE2","title":"Study on the Efficacy and Safety of the TmBU Conditioning Regimen in High-risk or Relapsed/Refractory Acute Leukemia","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2025-01-30","conditions":"Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Transplantation, Stem Cell","enrollment":48},{"nctId":"NCT02114229","phase":"PHASE2","title":"Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2014-05-14","conditions":"Malignant Rhabdoid Tumor, Atypical Teratoid Rhabdoid Tumor","enrollment":125},{"nctId":"NCT05663866","phase":"PHASE2","title":"Premedication to Reduce Amivantamab Associated Infusion Related Reactions","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2023-05-18","conditions":"Carcinoma, Non-Small-Cell Lung","enrollment":68},{"nctId":"NCT05292664","phase":"PHASE1","title":"Venetoclax Basket Trial for High Risk Hematologic Malignancies","status":"RECRUITING","sponsor":"Andrew E. Place, MD","startDate":"2023-03-29","conditions":"Myelodysplastic Syndromes, de Novo, Myelodysplastic Syndromes, Secondary, Myelodysplastic Syndromes, Previously Treated","enrollment":30},{"nctId":"NCT06177067","phase":"PHASE1","title":"Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia","status":"RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2024-04-19","conditions":"Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia, Acute Leukemia of Ambiguous Lineage","enrollment":24},{"nctId":"NCT07446400","phase":"PHASE1","title":"A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together","status":"NOT_YET_RECRUITING","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2026-03-20","conditions":"Healthy Volunteers","enrollment":48},{"nctId":"NCT05535166","phase":"PHASE2","title":"Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma","status":"RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2022-12-20","conditions":"Medulloblastoma","enrollment":130},{"nctId":"NCT07386587","phase":"PHASE3","title":"Methotrexate Alone vs Methotrexate + Etanercept for Minimal/Low Disease Activity in Juvenile Idiopathic Arthritis","status":"ENROLLING_BY_INVITATION","sponsor":"University of Child Health Sciences and Children's Hospital, Lahore","startDate":"2026-01-27","conditions":"Juvenile Idiopathic Arthritis","enrollment":60},{"nctId":"NCT07381556","phase":"PHASE4","title":"Cyclosporine Or Methotrexate for Pediatric Alopecia Areata: Routine Clinical Care Effectiveness Study","status":"RECRUITING","sponsor":"Erasmus Medical Center","startDate":"2025-11-01","conditions":"Alopecia Areata(AA), Alopecia Areata (AA), Alopecia Totalis/Universalis","enrollment":50},{"nctId":"NCT07337434","phase":"EARLY_PHASE1","title":"To Check Comparison of Apremilast and Methotrexate Efficacy in Patients With Moderate to Severe Plaque Psoriasis Presented to Tertiary Care Hospital","status":"RECRUITING","sponsor":"Syeda Sana Zaman","startDate":"2025-12-25","conditions":"Chronic Plaque Psoriasis","enrollment":106},{"nctId":"NCT05814627","phase":"PHASE3","title":"Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis","status":"ACTIVE_NOT_RECRUITING","sponsor":"AbbVie","startDate":"2023-06-15","conditions":"Rheumatoid Arthritis","enrollment":487},{"nctId":"NCT01856478","phase":"PHASE3","title":"LUX-Head&Neck 3: Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2013-06-07","conditions":"Head and Neck Neoplasms","enrollment":340},{"nctId":"NCT04579848","phase":"PHASE4","title":"Methotrexate in Erosive Inflammatory Hand Osteoarthritis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Diakonhjemmet Hospital","startDate":"2021-08-12","conditions":"Hand Osteoarthritis, Erosive Osteoarthritis","enrollment":163},{"nctId":"NCT06615050","phase":"PHASE3","title":"A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)","status":"RECRUITING","sponsor":"Incyte Corporation","startDate":"2025-04-02","conditions":"Graft-versus-host Disease (GVHD)","enrollment":572},{"nctId":"NCT04483466","phase":"PHASE3","title":"Methotrexate Treatment of Arthritis Caused by Chikungunya Virus (MARCH)","status":"ACTIVE_NOT_RECRUITING","sponsor":"George Washington University","startDate":"2023-07-18","conditions":"Investigate the Effect(s) of Methotrexate Treatment on Arthritis Disease Severity","enrollment":150},{"nctId":"NCT06682169","phase":"PHASE3","title":"Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host Disease","status":"RECRUITING","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2024-11-20","conditions":"Graft-versus-host Disease","enrollment":182},{"nctId":"NCT03589326","phase":"PHASE3","title":"A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Takeda","startDate":"2018-10-04","conditions":"Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)","enrollment":245},{"nctId":"NCT05166304","phase":"PHASE1, PHASE2","title":"Rebamipide in Patients With Active Rheumatoid Arthritis","status":"COMPLETED","sponsor":"October 6 University","startDate":"2024-01-01","conditions":"Rheumatoid Arthritis","enrollment":60},{"nctId":"NCT07227584","phase":"PHASE2","title":"ALL Backbone in AYAs","status":"NOT_YET_RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2026-04","conditions":"Acute Lymphoblastic Leukemia, Philadelphia Chromosome-Negative Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia (ALL)","enrollment":67},{"nctId":"NCT06671054","phase":"PHASE2","title":"A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid Arthritis","status":"RECRUITING","sponsor":"SynAct Pharma Aps","startDate":"2024-10-01","conditions":"Rheumatoid Arthritis (RA)","enrollment":240},{"nctId":"NCT04501614","phase":"PHASE1, PHASE2","title":"A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia","status":"TERMINATED","sponsor":"Takeda","startDate":"2021-02-24","conditions":"Pediatric Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL), Ph+ Mixed Phenotype Acute Leukemia (MPAL), Philadelphia Chromosome-Like ALL (Ph-like ALL)","enrollment":11},{"nctId":"NCT05579769","phase":"PHASE2","title":"Pediatric Study of GVHD Ppx w/o Calcineurin Inhibitors After Day60 Post First Allo HSCT for Hematological Malignancies.","status":"TERMINATED","sponsor":"St. Jude Children's Research Hospital","startDate":"2023-03-14","conditions":"Hematologic Malignancy, Myeloid Malignancy","enrollment":3},{"nctId":"NCT00809172","phase":"PHASE3","title":"Study of Methotrexate Efficacy Versus Cyclosporine in Moderate to Severe Atopic Dermatitis Patients","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2008-12","conditions":"Atopic Dermatitis","enrollment":100},{"nctId":"NCT05658640","phase":"PHASE1, PHASE2","title":"HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies","status":"RECRUITING","sponsor":"Princess Maxima Center for Pediatric Oncology","startDate":"2023-11-14","conditions":"Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent","enrollment":26},{"nctId":"NCT03775460","phase":"NA","title":"Methotrexate and Prednisolone Study in Erythema Nodosum Leprosum","status":"ACTIVE_NOT_RECRUITING","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2023-01-15","conditions":"Erythema Nodosum Leprosum","enrollment":550},{"nctId":"NCT03860844","phase":"PHASE2","title":"Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia","status":"TERMINATED","sponsor":"Sanofi","startDate":"2019-08-06","conditions":"Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia","enrollment":67},{"nctId":"NCT06476366","phase":"EARLY_PHASE1","title":"Comparison of Efficacy of Methotrexate and Azathioprine in Patients With Chronic Actinic Dermatitis: A Randomized Controlled Trial","status":"COMPLETED","sponsor":"Pak Emirates Military Hospital","startDate":"2024-07-14","conditions":"Chronic Actinic Dermatitis","enrollment":20},{"nctId":"NCT02629159","phase":"PHASE3","title":"A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate","status":"ACTIVE_NOT_RECRUITING","sponsor":"AbbVie","startDate":"2015-12-01","conditions":"Rheumatoid Arthritis","enrollment":1629},{"nctId":"NCT07089381","phase":"NA","title":"Efficacy and Safety of Resveratrol in Patients With Rheumatoid Arthritis.","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2025-08-01","conditions":"Rheumatic Arthritis, Rheumatoid Arthritis (RA) Prevention, Inflamation","enrollment":118},{"nctId":"NCT06504082","phase":"NA","title":"Comparison of the Effectiveness of Single-Dose Methotrexate Protocol With Letrozole + Single-Dose Methotrexate in the Medical Treatment of Patients Diagnosed With Ectopic Pregnancy","status":"COMPLETED","sponsor":"Yuzuncu Yil University","startDate":"2021-09-20","conditions":"Ectopic Pregnancy","enrollment":60},{"nctId":"NCT04068246","phase":"PHASE1, PHASE2","title":"The AMPK Modulator Metformin as a Novel Adjunct to Conventional Therapy in Rheumatoid Arthritis Patients","status":"COMPLETED","sponsor":"Sadat City University","startDate":"2019-08-01","conditions":"Rheumatoid Arthritis","enrollment":120},{"nctId":"NCT06073093","phase":"PHASE2","title":"A Study to Evaluate SAR441566 Efficacy and Safety in Adults With Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Sanofi","startDate":"2023-11-07","conditions":"Rheumatoid Arthritis","enrollment":264},{"nctId":"NCT05756179","phase":"PHASE3","title":"Effect of Diosmin and Hesperidin in Treatment of Patients With Rheumatoid Arthritis","status":"RECRUITING","sponsor":"Alexandria University","startDate":"2023-07-18","conditions":"Rheumatoid Arthritis","enrollment":80},{"nctId":"NCT06231745","phase":"PHASE3","title":"Paroxetine Safety and Efficacy in Rheumatoid Arthritis","status":"RECRUITING","sponsor":"Mostafa Bahaa","startDate":"2024-01-31","conditions":"Rheumatoid Arthritis","enrollment":100},{"nctId":"NCT01242917","phase":"PHASE2","title":"A Study to Evaluate the Safety and Efficacy of CCX354-C in Subjects With Rheumatoid Arthritis Partially Responsive to Methotrexate Therapy","status":"COMPLETED","sponsor":"Amgen","startDate":"2010-09","conditions":"Rheumatoid Arthritis","enrollment":159},{"nctId":"NCT05374785","phase":"PHASE2","title":"Efficacy and Safety Study Comparing CPL409116 to Placebo in Participants With Active Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Celon Pharma SA","startDate":"2022-05-01","conditions":"Rheumatoid Arthritis","enrollment":106},{"nctId":"NCT02299999","phase":"PHASE2","title":"SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"UNICANCER","startDate":"2014-04-07","conditions":"Metastatic Breast Cancer","enrollment":1460},{"nctId":"NCT05353829","phase":"PHASE4","title":"Methotrexate in Patients with Early Rheumatoid Arthritis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Region Västerbotten","startDate":"2022-04-28","conditions":"Rheumatoid Arthritis","enrollment":212},{"nctId":"NCT01976182","phase":"PHASE2","title":"Prospective, Multicentric, Phase II Randomized Controlled Trial on Two Parallel Groups Comparing the Efficacy of Two Immunosuppressive Drugs (methotrexate, Cyclophosphamide) in Large Granular Lymphocytes Leukemia","status":"COMPLETED","sponsor":"Rennes University Hospital","startDate":"2013-11-26","conditions":"Large Granular Lymphocytes Leukemia","enrollment":166},{"nctId":"NCT06768294","phase":"PHASE2","title":"Baricitinib in CPPD - the BAPTIST Study","status":"NOT_YET_RECRUITING","sponsor":"I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio","startDate":"2025-01","conditions":"Calcium Pyrophosphate Deposition Disease, Chondrocalcinosis","enrollment":32},{"nctId":"NCT06724952","phase":"PHASE4","title":"Effect of Silymarin in Rheumatoid Arthritis Patients Treated With Methotrexate","status":"NOT_YET_RECRUITING","sponsor":"Tanta University","startDate":"2024-12-10","conditions":"Rheumatoid Arthritis (RA)","enrollment":44},{"nctId":"NCT03593759","phase":"PHASE3","title":"Cardiac Sarcoidosis Randomized Trial","status":"RECRUITING","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2019-01-15","conditions":"Cardiac Sarcoidosis, Sarcoidosis","enrollment":194},{"nctId":"NCT06712238","phase":"NA","title":"Evaluation The Effect of NB-UVB and Methotrexate on The Level of Serum Gelsolin in Psoriatic Patients","status":"RECRUITING","sponsor":"Aswan University","startDate":"2024-06-10","conditions":"Psoriatic Conditions","enrollment":48},{"nctId":"NCT06297096","phase":"PHASE3","title":"Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease","status":"NOT_YET_RECRUITING","sponsor":"National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland","startDate":"2025-01-01","conditions":"Systemic Sclerosis, Interstitial Lung Disease","enrollment":86},{"nctId":"NCT05604885","phase":"PHASE2","title":"A Dose-range Study of the Safety and Efficacy of Treatment in Adult Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate","status":"COMPLETED","sponsor":"SynAct Pharma Aps","startDate":"2022-11-30","conditions":"Rheumatoid Arthritis","enrollment":125},{"nctId":"NCT02305849","phase":"PHASE3","title":"A Study to Evaluate Efficacy and Safety of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate (MTX) Treatment","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2014-07-25","conditions":"Rheumatoid Arthritis","enrollment":519},{"nctId":"NCT05522582","phase":"PHASE2","title":"Methotrexate Combined With Immunotherapy During Radiotherapy for Solid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yancheng First People's Hospital","startDate":"2021-11-15","conditions":"Solid Tumors","enrollment":50},{"nctId":"NCT06641128","phase":"PHASE4","title":"The Possible Efficacy and Protective Effect of Empagliflozin in Rheumatoid Arthritis Patients Treated with Methotrexate","status":"NOT_YET_RECRUITING","sponsor":"Tanta University","startDate":"2024-10-15","conditions":"Rheumatoid Arthritis (RA), Methotrexate Induced Nephrotoxicity, Methotrexate Adverse Reaction","enrollment":44},{"nctId":"NCT06498089","phase":"PHASE4","title":"A Randomized, Controlled, Open-label, Multicenter Clinical Trial Comparing the Efficacy and Safety of a Precision Treatment Regimen Based on Clinical-molecular Phenotypes with a Conventional Treatment Regimen in the Treatment of Patients with Active Takayasu's Arteritis","status":"RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2024-06-28","conditions":"Takayasu Arteritis","enrollment":124},{"nctId":"NCT06640309","phase":"PHASE2","title":"The Effect of Nicotinamide on the Clinical Outcome of Rheumatoid Arthritis Patients","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2023-12-02","conditions":"Rheumatoid Arthritis","enrollment":70},{"nctId":"NCT05102448","phase":"PHASE4","title":"Comparison of Tofacitinib and Methotrexate in Takayasu's Arteritis","status":"RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2021-11-01","conditions":"Takayasu Arteritis","enrollment":76},{"nctId":"NCT05279417","phase":"PHASE2","title":"ATI-450 Plus Methotrexate (MTX) Versus Placebo Plus MTX in Participants With Moderate to Severe Active Rheumatoid Arthritis (RA)","status":"COMPLETED","sponsor":"Aclaris Therapeutics, Inc.","startDate":"2022-02-01","conditions":"Rheumatoid Arthritis","enrollment":251},{"nctId":"NCT01393639","phase":"PHASE2","title":"Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Pfizer","startDate":"2011-09-27","conditions":"Rheumatoid Arthritis","enrollment":323},{"nctId":"NCT06454266","phase":"PHASE2","title":"First-line Treatment of PCNSL With the Combination of Orelabrutinib, Rituximab, and Methotrexate (ORM Regimen)","status":"COMPLETED","sponsor":"Ningbo No. 1 Hospital","startDate":"2021-12-28","conditions":"Primary Central Nervous System Lymphoma","enrollment":22},{"nctId":"NCT02065700","phase":"PHASE2","title":"Long-term Follow-up Study of GLPG0634 in Active Rheumatoid Arthritis Participants","status":"COMPLETED","sponsor":"Galapagos NV","startDate":"2014-02-25","conditions":"Rheumatoid Arthritis","enrollment":739},{"nctId":"NCT06426979","phase":"NA","title":"Sequential Letrozole and Methotrexate Therapy Role in Treatment of Tubal Ectopic Pregnancy","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2023-01-01","conditions":"Pregnancy Tubal","enrollment":200},{"nctId":"NCT04311567","phase":"PHASE4","title":"Effects of Tofacitinib vs Methotrexate on Rheumatoid Arthritis Interstitial Lung Disease","status":"TERMINATED","sponsor":"Vastra Gotaland Region","startDate":"2020-11-07","conditions":"Rheumatoid Arthritis, Interstitial Lung Disease Due to Systemic Disease (Disorder), RA","enrollment":3},{"nctId":"NCT00847613","phase":"PHASE3","title":"A 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate","status":"COMPLETED","sponsor":"Pfizer","startDate":"2009-03","conditions":"Arthritis, Rheumatoid","enrollment":800},{"nctId":"NCT06354439","phase":"PHASE4","title":"Use of Letrozole for Ectopic Pregnancy","status":"RECRUITING","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2024-03-27","conditions":"Ectopic Pregnancy","enrollment":130},{"nctId":"NCT04809623","phase":"PHASE1","title":"Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE)","status":"TERMINATED","sponsor":"Gilead Sciences","startDate":"2021-09-01","conditions":"Cutaneous Lupus Erythematosus","enrollment":3},{"nctId":"NCT03980483","phase":"PHASE3","title":"Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2019-05-16","conditions":"Arthritis, Rheumatoid","enrollment":1537},{"nctId":"NCT05918718","phase":"PHASE1, PHASE2","title":"Assessment of the Efficacy of Letrozole in the Treatment of Ectopic Pregnancy","status":"UNKNOWN","sponsor":"Tehran University of Medical Sciences","startDate":"2023-01-20","conditions":"Ectopic Pregnancy","enrollment":150},{"nctId":"NCT03815448","phase":"NA","title":"Methotrexate in the Treatment of Advanced Knee Osteoarthritis With Effusion-synovitis","status":"COMPLETED","sponsor":"Zhujiang Hospital","startDate":"2019-07-18","conditions":"Knee Osteoarthritis, Effusion Synovial, Knee Pain","enrollment":215},{"nctId":"NCT05447520","phase":"PHASE2","title":"Montelukast Use in Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Noha Mansour","startDate":"2021-12-15","conditions":"Rheumatoid Arthritis","enrollment":92},{"nctId":"NCT02706951","phase":"PHASE3","title":"A Study Comparing Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to MTX (SELECT-MONOTHERAPY)","status":"COMPLETED","sponsor":"AbbVie","startDate":"2016-03-23","conditions":"Rheumatoid Arthritis","enrollment":648},{"nctId":"NCT05380934","phase":"PHASE1","title":"A Clinical Trial of Safety and Tolerance of TQH3821 Tablets in Adult Healthy Subjects","status":"COMPLETED","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2022-05-29","conditions":"Rheumatoid Arthritis","enrollment":63},{"nctId":"NCT06154590","phase":"","title":"Anastrozole Adjuvant Trial - Study of Anastrozole Compared to NOLVADEX (Tamoxifen Citrate) for Adjuvant Treatment of Early Breast Cancer Clinical Studies), Adjunct Cytotoxic Chemotherapy and Malignant Joint Tumor","status":"NOT_YET_RECRUITING","sponsor":"DR. DIANE CHISESI NFS. MD. PHD.","startDate":"2024-07","conditions":"Metastatic Breast Cancer, Tumor, Muscle Neoplasms","enrollment":100},{"nctId":"NCT05660655","phase":"PHASE4","title":"Efficacy and Safety of Baricitinib for the Treatment of Moderate to Severe Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","startDate":"2022-10-01","conditions":"Rheumatoid Arthritis","enrollment":94},{"nctId":"NCT03855007","phase":"PHASE4","title":"The Clinical Efficacy and Safety of Iguratimod in RA and Early RA Patients for 6 Months Treatment","status":"COMPLETED","sponsor":"Qilu Hospital of Shandong University","startDate":"2016-01-01","conditions":"Arthritis, Rheumatoid","enrollment":400},{"nctId":"NCT05133297","phase":"PHASE2","title":"The Safety and Efficacy of TLL-018 in Active Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Hangzhou Highlightll Pharmaceutical Co., Ltd","startDate":"2022-02-16","conditions":"Rheumatoid Arthritis","enrollment":101},{"nctId":"NCT02764762","phase":"PHASE4","title":"Triple Combination Therapy in High Risk Crohn's Disease (CD)","status":"COMPLETED","sponsor":"Takeda","startDate":"2017-04-18","conditions":"Crohn Disease","enrollment":55},{"nctId":"NCT02706873","phase":"PHASE3","title":"A Study to Compare Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have Not Previously Taken Methotrexate","status":"COMPLETED","sponsor":"AbbVie","startDate":"2016-02-23","conditions":"Rheumatoid Arthritis","enrollment":1002},{"nctId":"NCT05684744","phase":"PHASE2, PHASE3","title":"Roflumilast Versus Methotrexate in Psoriasis","status":"COMPLETED","sponsor":"Cairo University","startDate":"2023-01-09","conditions":"Psoriasis","enrollment":30},{"nctId":"NCT03965728","phase":"PHASE1","title":"Study to Investigate Safety, Tolerability, Pharmacokinetics, and Drug-drug Interaction of Multiple Oral Doses of BAY1830839 in Healthy Male Participants","status":"COMPLETED","sponsor":"Bayer","startDate":"2019-06-05","conditions":"Healthy Volunteers","enrollment":67},{"nctId":"NCT04341545","phase":"PHASE3","title":"Letrozole in Tubal Ectopic Pregnancy","status":"UNKNOWN","sponsor":"Queen Mary Hospital, Hong Kong","startDate":"2020-12-01","conditions":"Tubal Pregnancy","enrollment":214},{"nctId":"NCT04247815","phase":"PHASE2","title":"Study of ATI-450 Plus Methotrexate (MTX) vs MTX Alone in Patients With Moderate to Severe RA","status":"COMPLETED","sponsor":"Aclaris Therapeutics, Inc.","startDate":"2020-03-16","conditions":"Rheumatoid Arthritis","enrollment":25},{"nctId":"NCT04038970","phase":"PHASE2","title":"Efficacy and Safety Study of KN019 in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate","status":"COMPLETED","sponsor":"Jiangsu Alphamab Biopharmaceuticals Co., Ltd","startDate":"2019-11-08","conditions":"Rheumatoid Arthritis","enrollment":145},{"nctId":"NCT03194932","phase":"PHASE1","title":"Study of Venetoclax in Combination With Chemotherapy in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Leukemia of Ambiguous Lineage","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"2017-07-11","conditions":"Acute Myeloid Leukemia","enrollment":62},{"nctId":"NCT02913261","phase":"PHASE3","title":"Safety and Efficacy of Ruxolitinib Versus Best Available Therapy in Patients With Corticosteroid-refractory Acute Graft vs. Host Disease After Allogeneic Stem Cell Transplantation","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2017-03-10","conditions":"Corticosteroid Refractory Acute Graft vs Host Disease","enrollment":310},{"nctId":"NCT02373813","phase":"PHASE3","title":"Study of Etanercept Monotherapy vs Methotrexate Monotherapy for Maintenance of Rheumatoid Arthritis Remission","status":"COMPLETED","sponsor":"Amgen","startDate":"2015-02-20","conditions":"Rheumatoid Arthritis","enrollment":371},{"nctId":"NCT05626348","phase":"PHASE4","title":"The Clinical Efficacy of Immunomodulators in RA Patients","status":"RECRUITING","sponsor":"Qilu Hospital of Shandong University","startDate":"2021-12-22","conditions":"Arthritis, Rheumatoid","enrollment":400},{"nctId":"NCT04537689","phase":"PHASE4","title":"Outcomes With Treatment and Withdraw of Ixekizumab in Patients With Plaque Psoriasis","status":"RECRUITING","sponsor":"Singapore General Hospital","startDate":"2020-12-10","conditions":"Plaque Psoriasis","enrollment":40},{"nctId":"NCT04239859","phase":"PHASE4","title":"Outcomes With Treatment and Withdraw of Secukinumab in Patients With Plaque Psoriasis","status":"NOT_YET_RECRUITING","sponsor":"Singapore General Hospital","startDate":"2024-01","conditions":"Plaque Psoriasis","enrollment":40},{"nctId":"NCT05575297","phase":"PHASE1","title":"A Drug-drug Interaction Study to Evaluate the Effect of Rifampicin and Febuxostat on the Pharmacokinetics of Methotrexate in Healthy Subjects","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2021-12-20","conditions":"Drug Interaction","enrollment":12},{"nctId":"NCT05393050","phase":"PHASE4","title":"Efficacy and Safety of Colquhounia Root Tablet in Patients With Rheumatoid Arthritis","status":"UNKNOWN","sponsor":"Quan Jiang","startDate":"2022-07","conditions":"Rheumatoid Arthritis","enrollment":120},{"nctId":"NCT01373151","phase":"PHASE2","title":"Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to Methotrexate","status":"COMPLETED","sponsor":"CSL Behring","startDate":"2011-06","conditions":"Rheumatoid Arthritis","enrollment":418},{"nctId":"NCT01949116","phase":"PHASE2","title":"Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2014-01-31","conditions":"HIV Infections","enrollment":176},{"nctId":"NCT02366091","phase":"PHASE2","title":"Inflammation and Coronary Endothelial Function","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2015-01","conditions":"Coronary Artery Disease","enrollment":111},{"nctId":"NCT03163966","phase":"PHASE2","title":"A Study of the EP4 Antagonist CR6086 in Combination With Methotrexate, in DMARD-naïve Patients With Early Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Rottapharm Biotech","startDate":"2017-10-05","conditions":"Rheumatoid Arthritis, DMARD-naive and Early Disease Patients","enrollment":248},{"nctId":"NCT02066389","phase":"PHASE2","title":"A Study Investigating the Efficacy and Safety of Upadacitinib (ABT-494) Given With Methotrexate (MTX) in Adults With Rheumatoid Arthritis Who Have Had an Inadequate Response to MTX Alone","status":"COMPLETED","sponsor":"AbbVie","startDate":"2014-03-26","conditions":"Rheumatoid Arthritis","enrollment":300},{"nctId":"NCT04944524","phase":"PHASE4","title":"Comparison of Tofacitinib and Methotrexate in the Maintained Treatment of GPA","status":"UNKNOWN","sponsor":"Shanghai Zhongshan Hospital","startDate":"2021-07-01","conditions":"Granulomatosis With Polyangiitis","enrollment":66},{"nctId":"NCT02504268","phase":"PHASE3","title":"Effects of Abatacept in Patients With Early Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2015-09-03","conditions":"Rheumatoid Arthritis","enrollment":994},{"nctId":"NCT02889796","phase":"PHASE3","title":"Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2016-08-30","conditions":"Rheumatoid Arthritis","enrollment":1759},{"nctId":"NCT02886728","phase":"PHASE3","title":"Filgotinib Alone and in Combination With Methotrexate (MTX) in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Are Naive to MTX Therapy","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2016-08-08","conditions":"Rheumatoid Arthritis","enrollment":1252},{"nctId":"NCT02873936","phase":"PHASE3","title":"Filgotinib Versus Placebo in Adults With Active Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Biologic Disease-modifying Anti-rheumatic Drug(s) (DMARDs) Treatment","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2016-07-27","conditions":"Rheumatoid Arthritis","enrollment":449},{"nctId":"NCT03692416","phase":"PHASE3","title":"The Effect of Some Drugs Used in Treatment of Vasculitis on the Complement System in Children","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2018-11-11","conditions":"Vasculitis","enrollment":70},{"nctId":"NCT02504671","phase":"PHASE2","title":"Study to Evaluate the Efficacy and Safety of GSK3196165 Plus Methotrexate in Subjects With Active Moderate-Severe Rheumatoid Arthritis","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2015-07-23","conditions":"Arthritis, Rheumatoid","enrollment":222},{"nctId":"NCT02799472","phase":"PHASE2","title":"Mechanistic Study of GSK3196165 Plus Methotrexate (MTX) in Subjects With Active Rheumatoid Arthritis","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2016-06-15","conditions":"Arthritis, Rheumatoid","enrollment":39},{"nctId":"NCT01578499","phase":"PHASE3","title":"A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study)","status":"COMPLETED","sponsor":"Millennium Pharmaceuticals, Inc.","startDate":"2012-06-11","conditions":"Primary Cutaneous Anaplastic Large Cell Lymphoma, Mycosis Fungoides, Cutaneous T-Cell Lymphoma","enrollment":131},{"nctId":"NCT02647762","phase":"PHASE3","title":"CF101 Therapy Compared to Methotrexate Therapy for Active Rheumatoid Arthritis","status":"TERMINATED","sponsor":"Can-Fite BioPharma","startDate":"2017-10-30","conditions":"Rheumatoid Arthritis","enrollment":244}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":25,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["MTX","methotrexate pills"],"phase":"marketed","status":"active","brandName":"Methotrexate tablets","genericName":"Methotrexate tablets","companyName":"Yancheng First People's Hospital","companyId":"yancheng-first-people-s-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Methotrexate inhibits dihydrofolate reductase, blocking the synthesis of purines and pyrimidines required for DNA replication and cell division. Used for Acute lymphoblastic leukemia (ALL), Osteosarcoma, Breast cancer.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}